Human T-Cell Lymphotropic Virus 1, 2 (HTLV-1/HTLV-2) Differentiation

Alphabetical Test listing

Human T-Cell Lymphotropic Virus 1, 2 (HTLV-1/HTLV-2) Differentiation-994

  
Human T-Cell Lymphotropic Virus 1, 2 (HTLV-1/HTLV-2) Differentiation
  
994
  
LAB994
  
MSO
  
HTLV-I/HTLV-II
  
HTLV-I
HTLV-II
  

HTLV-1 infections can be confirmed and differentiated from HTLV-2 infections by using highly purified recombinant proteins or synthetic peptides which are either type common or type specific

  

This test is not for screening purposes and should be used as supplementary testing for patients previously identified as reactive for antibodies to HTLV.

  
Serum
  
0.5 mL
  
0.25 mL
  

Immediately following collection, mix sample by gently inverting 5 times

  

Gold:

  1. Allow sample to clot

  2. Spin within 2 hours of sample collection

Red:

  1. Allow sample to clot

  2. Spin within 2 hours of sample collection

  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled serum
  
EDTA plasma
  
  
0.5 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  
  1. Spin within 2 hours of sample collection

  2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled plasma
  
  

Refrigerated (preferred) - 7 days

Frozen - 6 months

  

Gross bacterial contamination; hemolysis; lipemia

  
LabCorp (164129): R-LC
  
We, Fr
  
2 - 6 days
  

Line immunoassay or immunoblot

  

Negative

  
86687
86688
  
03/29/2023
  
04/07/2023
  
04/07/2023